The PTZ AUTO 2 is a semi-automated tablet disintegration test instrument. It allows the entry and recall of stored methods for both testing positions. The baskets can be started and stopped independently and will be always moved to the upper position outside the disintegration media. With the levels of security and results reporting now specified by FDA regulations, this instrument fulfils all these requirements, yet offers an easy interface for routine use. A print out of the method, medium and results gives a permanent record of the test. All of the PTZ AUTO series of semi-automated tablet disintegration test instruments meet the specifications of USP and EP monographs in full.

Detection : Manual
Display : LCD Display 8 x 8 cm
Keyboard : alpha-numerical keys and function keys
OQ information : programmable time sequence information to perform OQ test
Security : password protected instrument calibration and validation procedures
Testing time : programmable testing time from 1 second up to 59h, 59m, 59s
Test Stations : Available from 1 until 4 baskets
Thermostat : water bath temperature programmable from 30.0 - 45.0oC
Accuracy : +/- 0.3oC
Stroke Frequency : 30 per minute
Accuracy : +/- 1 stroke
Stroke Height : 55 mm
Accuracy : +/- 1 mm

Source :

About Us

PT. Pharma Test Indonesia was established at the end of 2009. We are the subsidiary of Pharma Test AG (Germany) in South East Asia which supplies machines for Pharmaceutical Industry. As a part of Pharma Test commitment to Indonesian market, the company was established to fulfill the need for high quality testing equipments and supported with excellent after-sales service. Our company also supported the Pharma Test agents in South East Asia especially for the technical support.


Contact Us

Anda bisa menghubungi kami untuk lebih detail terkait produk dan layanan kami.

PT. Pharma Test Indonesia
Rukan Crown Blok A No.8
Green Lake City
Tangerang 15147

Phone: +6221 54318816
Mobile. +62 851 00902797

Technical Support:


Subscribe to our newsletter to get latest updates from us.